NOW RECRUITING: Patients with Pulmonary Arterial Hypertension (PAH) for IMPAHCT,
a Phase 2b/3 study evaluating AV-101. Learn more about the study.

Why Aerovate

Aerovate fosters an uplifting environment, collaborative peers, and a passion for learning that translates into making a difference for people with cardiopulmonary disease and their communities.

Aerovate’s culture is one of inclusion, excellence and respect in every way – for each other, the science, the community, and our mission. Both at work and in the clinic, we are committed to recruiting individuals that exemplify diversity in culture and life experience and are always striving to grow and improve. We recognize the urgency of our efforts and we accept the challenge to do what’s right for our patients and their communities.


This is really a great group of people who believe in the importance of treating one another with respect and dignity and inclusion and kindness and support.”

Aerovate has created a safe place for everyone to come with their true self and feel that they belong. I can express my own personality and bring new ideas to the team because I know they will be heard, valued and respected.”

We want to continue to be able to attract people that want to move quickly to develop these drugs that have a lot of promise for patients that have great unmet medical need.”

People enjoy coming to work and making progress within their various roles. It’s very refreshing to see that and inspires you to contribute your best.”

The people here are dedicated and focused, and that keeps me confident that we will achieve the goals that we’ve set out to accomplish.”